Islet cell failure in type 2 diabetes
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index; none of the 272 sources its claims cite is checked for support yet.
Abstract
The major focus of this Review is on the mechanisms of islet beta cell failure in the pathogenesis of obesity-associated type 2 diabetes (T2D). As this demise occurs within the context of beta cell compensation for insulin resistance, consideration is also given to the mechanisms involved in the compensation process, including mechanisms for expansion of beta cell mass and for enhanced beta cell performance. The importance of genetic, intrauterine, and environmental factors in the determination of "susceptible" islets and overall risk for T2D is reviewed. The likely mechanisms of beta cell failure are discussed within the two broad categories: those with initiation and those with progression roles.
Overview
CoChat Summary
## TL;DR
This is a 2006 review arguing that type 2 diabetes develops when insulin-resistant islets can no longer sustain compensatory b cell function, leading first to dysfunction and then progressive loss of b cell mass. It emphasizes that “susceptible” islets are shaped by genetic, intrauterine, and environmental factors, and that hyperglycemia accelerates damage through glucotoxic and glucolipotoxic mechanisms.
## Key findings
- In longitudinal studies, insulin levels rise during the normoglycemic and prediabetes phases and then decline when fasting glycemia exceeds the upper normal limit of 5.5 mM, marking b cell failure.
- A longitudinal study in Pima Indians found that b cell dysfunction was the major determinant of progression from normoglycemia to diabetes.
- In autopsy pancreata from 124 subjects, the paper reports a 40% and 63% loss of islet b cell volume in obese subjects with impaired fasting glucose and T2D, respectively, compared with weight-matched controls; lean T2D subjects had a 41% loss versus lean controls.
- The paper reports that the STOP-NIDDM trial showed acarbose treatment of IGT subjects reduced the risk of progression to diabetes by 36%.
## Methods
- Narrative review of mechanistic, animal, human postmortem, genetic, and epidemiologic studies on islet b cell compensation and failure in obesity-associated T2D.
- Synthesizes findings from rodent models (including ZF, ZDF, DBA2, GK, and IUGR models) and human islet/pancreas studies, including a transcript profiling study of 7 normal and 5 T2D human islet samples.
- Main analysis is integrative and conceptual: it organizes evidence into mechanisms that promote compensation and mechanisms with initiation versus progression roles in b cell failure.
## Limitations
- The paper states that the mechanisms of b cell compensation are “not fully understood,” and that the role of several proposed factors remains to be established or warrants further investigation.
- It explicitly notes uncertainty about several mechanisms, including whether nonimmune islet inflammation contributes in vivo, whether IAPP is causal in b cell dysfunction and demise, and whether reduced ARNT expression is an early defect or a consequence.
- Evident from the text: this is a review, not a new experimental study, so its conclusions depend on the quality and consistency of the cited animal and human studies rather than on a single primary dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 164 Not checked · 38 Own results and interpretations
In the paper
“Longitudinal studies of subjects that develop T2D show a rise in insulin levels in the normoglycemic and prediabetes phases that keep glycemia near normal despite the insulin resistance ( b cell compensation), followed by a decline when fasting glycemia surpasses the upper limit of normal of 5.5 mM ( b cell failure) (5) (Figure 1).”
What the sources say
- Not checked yetcites [5]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“With respect to the latter, increases were observed in enzymes and metabolites involved in anaplerosis and the malate-pyruvate and citratepyruvate shuttles of ZF islets (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of these pathways by phenylacetic acid, which inhibits PC, markedly impeded GSIS (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies of islet b cell compensation within models that maintain normoglycemia show upregulation of glucose metabolism pathways (12, 13, 31).”
What the sources say
- Not checked yetcites [12]
- Not checked yetcites [13]
- Not checked yetcites [31]
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A recent study in Zucker fatty (ZF) rats has provided strong support for PKB activation in the b cell growth response to insulin resistance in this normoglycemic model (11).”
What the sources say
- Not checked yetcites [11]
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 203 claims and to verify the 272 references still open.
- It may state two separate claims as one. 71
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, several of these studies have demonstrated that fatty acids do not induce beta-cell dysfunction in the absence of elevated glucose, highlighting that fatty acids and glucose are not cytotoxic independently.168,169”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, impairment of insulin secretion in the presence of an intact β-cell mass also occurs in the early stages of human age-related diabetes123.”
From The telomere syndromes (2012) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [75]
Experimental — accuracy not yet measured
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
The Pathophysiology of Gestational Diabetes Mellitus
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113342 · Cited by 1,874
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
BackgroundMoringa oleifera: A review on nutritive importance and its medicinal application
Gopalakrishnan, L., Doriya, K., & Kumar, D. S. (2016) · Food Science and Human Wellness · doi:10.1016/j.fshw.2016.04.001 · Cited by 1,374
The Role for Endoplasmic Reticulum Stress in Diabetes Mellitus
Eizirik, D. L., Cardozo, A. K., & Cnop, M. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0015 · Cited by 1,173
Glucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982
Type 2 diabetes across generations: from pathophysiology to prevention and management
Nolan, C. J., Damm, P., & Prentki, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60614-4 · Cited by 923
Self-citationXue, A., Wu, Y., Zhu, Z., Zhang, F., Kemper, K. E., Zheng, Z., Yengo, L., Lloyd-Jones, L. R., Sidorenko, J., Wu, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04951-w · Cited by 901
SGLT2 inhibition — a novel strategy for diabetes treatment
Chao, E. C., & Henry, R. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3180 · Cited by 822
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Yan, Y., Jiang, W., Spinetti, T., Tardivel, A., Castillo, R., Bourquin, C., Guarda, G., Tian, Z., Tschopp, J., & Zhou, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.015 · Cited by 784
“Proinflammatory cytokines, such as TNF-a and IL-1b, are significantly elevated in T2D (Herder et al., 2009; Spranger et al., 2003). u-3 FAs have been reported to enhance systemic insulin sensitivity via inhibition of TNF-a signaling pathway (Oh et al., 2010), however, some animal studies and several clinical trials us…”
BackgroundInfluentialWeng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., Hu, Y., Zhou, Z., Yan, X., Tian, H., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60762-x · Cited by 780
Yilmaz, B., Terekeci, H., Sandal, S., & Kelestimur, F. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09521-z · Cited by 748
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
List, J. F., Woo, V., Morales, E., Tang, W., & Fiedorek, F. T. (2009) · Diabetes Care · doi:10.2337/dc08-1863 · Cited by 698
Song, B., Scheuner, D., Ron, D., Pennathur, S., & Kaufman, R. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34587 · Cited by 693
Targeting inflammation in the treatment of type 2 diabetes: time to start
Donath, M. Y. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4275 · Cited by 690
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
Endoplasmic Reticulum Stress and Type 2 Diabetes
Back, S. H., & Kaufman, R. J. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072909-095555 · Cited by 619
Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.
Fu, Z., Gilbert, E. R., & Liu, D. (2013) · PubMed · Cited by 600
Modeling type 2 diabetes in rats using high fat diet and streptozotocin
Skovsø, S. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12235 · Cited by 596
Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis
Kaneto, H., Katakami, N., Matsuhisa, M., & Matsuoka, T.-A. (2010) · Mediators of Inflammation · doi:10.1155/2010/453892 · Cited by 575
Lawlor, N., George, J., Bolisetty, M., Kursawe, R., Sun, L., Sivakamasundari, V., Kycia, I., Robson, P., & Stitzel, M. L. (2017) · Genome Research · doi:10.1101/gr.212720.116 · Cited by 562
“5B, χ 2 P -value = 0.2733), and none of the islets fromthese newly diagnosed T2D individuals exhibited as significant a decrease as previously reported (Butler et al. 2003; Cnop et al. 2005; Donath et al. 2005; Prentki and Nolan 2006).”
InfluentialCirculating microRNAs as novel biomarkers for diabetes mellitus
Guay, C., & Regazzi, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.86 · Cited by 563
“One strand of the miRNA duplex can either associate to the RISC complex and guide translational repression of target mRNAs (4) or be released by the cells.”
BackgroundKong, L., Zhu, J., Han, W., Jiang, X., Xu, M., Zhao, Y., Dong, Q., Pang, Z., Guan, Q., Gao, L., et al. (2011) · Acta Diabetologica · doi:10.1007/s00592-010-0226-0 · Cited by 529
Saturated Fatty Acid and TLR Signaling Link β Cell Dysfunction and Islet Inflammation
Eguchi, K., Manabe, I., Oishi-Tanaka, Y., Ohsugi, M., Kono, N., Ogata, F., Yagi, N., Ohto, U., Kimoto, M., Miyake, K., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.023 · Cited by 519
Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose Homeostasis
Alvarez, J. A., & Ashraf, A. (2010) · International Journal of Endocrinology · doi:10.1155/2010/351385 · Cited by 481
The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation
Tornatore, L., Thotakura, A. K., Bennett, J., Moretti, M., & Franzoso, G. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.001 · Cited by 447
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Streptozotocin–nicotinamide-induced diabetes in the rat. Characteristics of the experimental model
Szkudelski, T. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.011372 · Cited by 436
Miller, M. E., Bonds, D. E., Gerstein, H. C., Seaquist, E. R., Bergenstal, R. M., Calles-Escandon, J., Childress, R. D., Craven, T. E., Cuddihy, R. M., Dailey, G., et al. (2010) · BMJ · doi:10.1136/bmj.b5444 · Cited by 429
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Ahrén, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2782 · Cited by 419
Targeting innate immune mediators in type 1 and type 2 diabetes
Donath, M. Y., Dinarello, C. A., & Mandrup-Poulsen, T. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0213-9 · Cited by 416
The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients
Marchetti, P., Bugliani, M., Lupi, R., Marselli, L., Masini, M., Boggi, U., Filipponi, F., Weir, G. C., Eizirik, D. L., & Cnop, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0816-8 · Cited by 413
“This imposes a stress on the beta cells, which may eventually fail to cope with the increased demand of insulin production, leading to the onset of diabetes [5–8].”
BackgroundInsulin resistance and pancreatic cell failure
Kasuga, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29189 · Cited by 412
Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus
Akash, M. S. H., Rehman, K., & Chen, S. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24402 · Cited by 407
“T2DM is simply characterized by uneven insulin secretion and its related effects [Robertson et al., 2004; Prentki and Nolan, 2006].”
BackgroundPancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin Therapy
Wang, Z., York, N. W., Nichols, C. G., & Remedi, M. S. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.010 · Cited by 406
“Type 2 diabetes is characterized by b cell dysfunction, the mechanism of which is controversial (Ahlqvist et al., 2011; Butler et al., 2003; Hur et al., 2010; Nolan and Prentki, 2008; Prentki and Nolan, 2006; Puri and Hebrok, 2012; Robertson et al., 2004; Talchai et al., 2012b; Wajchenberg, 2007).”
Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes
Tushuizen, M. E., Bunck, M. C., Pouwels, P. J., Bontemps, S., van Waesberghe, J. H. T., Schindhelm, R. K., Mari, A., Heine, R. J., & Diamant, M. (2007) · Diabetes Care · doi:10.2337/dc07-0326 · Cited by 400
Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
Yan, L.-J. (2014) · Journal of Diabetes Research · doi:10.1155/2014/137919 · Cited by 397
Komoroski, B., Vachharajani, N., Feng, Y., Li, L., Kornhauser, D., & Pfister, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.250 · Cited by 396
Thiazolidinediones: the forgotten diabetes medications
Lebovitz, H. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1270-y · Cited by 388
Emerging micro- and nanotechnology based synthetic approaches for insulin delivery
Mo, R., Jiang, T., Di, J., Tai, W., & Gu, Z. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60436e · Cited by 386
Endoplasmic reticulum stress and pancreatic β-cell death
Fonseca, S. G., Gromada, J., & Urano, F. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.02.008 · Cited by 384
Glucolipotoxicity of the pancreatic beta cell
Poitout, V., Amyot, J., Semache, M., Zarrouki, B., Hagman, D., & Fontés, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.08.006 · Cited by 382
Adipsin Is an Adipokine that Improves β Cell Function in Diabetes
Lo, J. C., Ljubicic, S., Leibiger, B., Kern, M., Leibiger, I. B., Moede, T., Kelly, M. E., Chatterjee Bhowmick, D., Murano, I., Cohen, P., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.005 · Cited by 381
“T2DM Patients with b Cell Failure Display Reduced Levels of Adipsin Human patients with T2DM develop evidence of b cell dysfunction (Ferrannini, 2010; Prentki and Nolan, 2006).”
Human islets contain four distinct subtypes of β cells
Dorrell, C., Schug, J., Canaday, P. S., Russ, H. A., Tarlow, B. D., Grompe, M. T., Horton, T., Hebrok, M., Streeter, P. R., Kaestner, K. H., et al. (2016) · Nature Communications · doi:10.1038/ncomms11756 · Cited by 378
“The clearly abnormal distribution of b cell subsets in the majority of our small T2D sample set raises the possibility that the subtypes differ in their susceptibility to metabolic stress 28,32 , proliferative capacity 33 or differentiation state 34 .”
Back, S. H., Scheuner, D., Han, J., Song, B., Ribick, M., Wang, J., Gildersleeve, R. D., Pennathur, S., & Kaufman, R. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.06.002 · Cited by 366
Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences
Leclercq, I. A., Da Silva Morais, A., Schroyen, B., Van Hul, N., & Geerts, A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.002 · Cited by 359
Endoplasmic Reticulum Stress: Its Role in Disease and Novel Prospects for Therapy
Schönthal, A. H. (2012) · Scientifica · doi:10.6064/2012/857516 · Cited by 353
Bellin, M. D., Barton, F. B., Heitman, A., Harmon, J. V., Kandaswamy, R., Balamurugan, A. N., Sutherland, D. E. R., Alejandro, R., & Hering, B. J. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03977.x · Cited by 350
JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
Solinas, G., & Karin, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-151340 · Cited by 347
Alterations in MicroRNA Expression Contribute to Fatty Acid–Induced Pancreatic β-Cell Dysfunction
Lovis, P., Roggli, E., Laybutt, D. R., Gattesco, S., Yang, J.-Y., Widmann, C., Abderrahmani, A., & Regazzi, R. (2008) · Diabetes · doi:10.2337/db07-1252 · Cited by 345
Mauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1146 · Cited by 341
β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes
Hudish, L. I., Reusch, J. E. B., & Sussel, L. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129188 · Cited by 336
Islet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes
Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., & Ehses, J. A. (2009) · Physiology · doi:10.1152/physiol.00032.2009 · Cited by 330
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · Figshare · Cited by 337
Glycerolipid Metabolism and Signaling in Health and Disease
Prentki, M., & Madiraju, S. R. M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0007 · Cited by 326
Self-citationDiabetes mellitus related bone metabolism and periodontal disease
Wu, Y.-Y., Xiao, E., & Graves, D. T. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2015.2 · Cited by 310
Unuofin, J. O., & Lebelo, S. L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1356893 · Cited by 308
New obesity classification criteria as a tool for bariatric surgery indication
Lorenzo, A. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.681 · Cited by 306
Frydrych, L. M., Bian, G., O’Lone, D. E., Ward, P. A., & Delano, M. J. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5vmr0118-021rr · Cited by 299
Diabetes mellitus, a microRNA-related disease?
Guay, C., Roggli, E., Nesca, V., Jacovetti, C., & Regazzi, R. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.009 · Cited by 300
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Steven, S., Oelze, M., Hanf, A., Kröller-Schön, S., Kashani, F., Roohani, S., Welschof, P., Kopp, M., Gödtel-Armbrust, U., Xia, N., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.06.009 · Cited by 298
“well as exhaustion of insulin content [44,45].”
Nolan, C. J., & Prentki, M. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827611 · Cited by 292
Self-citationNadal, A., Alonso-Magdalena, P., Soriano, S., Quesada, I., & Ropero, A. B. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.016 · Cited by 287
Jabbour, S. A., Hardy, E., Sugg, J., Parikh, & for the Study 10 Group (2014) · Diabetes Care · doi:10.2337/dc13-0467 · Cited by 286
“Due to a progressive loss of b-cell function (2), many patients eventually require multiple agents to achieve target hemoglobin A1c (HbA1c) levels (1).”
BackgroundSolinas, G., Naugler, W., Galimi, F., Lee, M.-S., & Karin, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607626103 · Cited by 284
Vitamin D deficiency and diabetes
Berridge, M. J. (2017) · Biochemical Journal · doi:10.1042/bcj20170042 · Cited by 265
Chronic Inflammation Links Cardiovascular, Metabolic and Renal Diseases
Manabe, I. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-1184 · Cited by 263
Transgenic pigs as models for translational biomedical research
Aigner, B., Renner, S., Kessler, B., Klymiuk, N., Kurome, M., Wünsch, A., & Wolf, E. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0610-9 · Cited by 258
Lovis, P., Gattesco, S., & Regazzi, R. (2008) · bchm · doi:10.1515/bc.2008.026 · Cited by 257
β Cell tone is defined by proglucagon peptides through cAMP signaling
Capozzi, M. E., Svendsen, B., Encisco, S. E., Lewandowski, S. L., Martin, M. D., Lin, H., Jaffe, J. L., Coch, R. W., Haldeman, J. M., MacDonald, P. E., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126742 · Cited by 250
Importance of oestrogen receptors to preserve functional β-cell mass in diabetes
Tiano, J. P., & Mauvais-Jarvis, F. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.242 · Cited by 250
Calcium release channel RyR2 regulates insulin release and glucose homeostasis
Santulli, G., Pagano, G., Sardu, C., Xie, W., Reiken, S., D’Ascia, S. L., Cannone, M., Marziliano, N., Trimarco, B., Guise, T. A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79273 · Cited by 238
Osteocalcin Promotes β-Cell Proliferation During Development and Adulthood Through Gprc6a
Wei, J., Hanna, T., Suda, N., Karsenty, G., & Ducy, P. (2014) · Diabetes · doi:10.2337/db13-0887 · Cited by 236
Rütti, S., Ehses, J. A., Sibler, R. A., Prazak, R., Rohrer, L., Georgopoulos, S., Meier, D. T., Niclauss, N., Berney, T., Donath, M. Y., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0252 · Cited by 237
Regulation of Pancreatic β Cell Mass by Neuronal Signals from the Liver
Imai, J., Katagiri, H., Yamada, T., Ishigaki, Y., Suzuki, T., Kudo, H., Uno, K., Hasegawa, Y., Gao, J., Kaneko, K., et al. (2008) · Science · doi:10.1126/science.1163971 · Cited by 236
Rosenstock, J., Sankoh, S., & List, J. F. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00876.x · Cited by 234
Nesca, V., Guay, C., Jacovetti, C., Menoud, V., Peyot, M.-L., Laybutt, D. R., Prentki, M., & Regazzi, R. (2013) · Diabetologia · doi:10.1007/s00125-013-2993-y · Cited by 234
“Insulin resistance is normally compensated by expansion of the beta cell mass and a rise in the insulin secretory activity [1].”
BackgroundSelf-citationNatural history of β-cell adaptation and failure in type 2 diabetes
Alejandro, E. U., Gregg, B., Blandino-Rosano, M., Cras-Méneur, C., & Bernal-Mizrachi, E. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.002 · Cited by 232
Pancreatic Ectopic Fat Is Characterized by Adipocyte Infiltration and Altered Lipid Composition
Pinnick, K. E., Collins, S. C., Londos, C., Gauguier, D., Clark, A., & Fielding, B. A. (2008) · Obesity · doi:10.1038/oby.2007.110 · Cited by 226
Cytokine production by islets in health and diabetes: cellular origin, regulation and function
Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., Halban, P. A., & Ehses, J. A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.010 · Cited by 227
β-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225
“and inhibition of acetyl-CoA carboxylase or via down regulation of the transcription factor sterol-regulatoryelement-binding-protein-1c (SREBP1c) [99, 137].”
Pdx1 ( MODY4 ) regulates pancreatic beta cell susceptibility to ER stress
Sachdeva, M. M., Claiborn, K. C., Khoo, C., Yang, J., Groff, D. N., Mirmira, R. G., & Stoffers, D. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904849106 · Cited by 221
Insulin Signaling in the Pancreatic β-Cell
Leibiger, I. B., Leibiger, B., & Berggren, P.-O. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155530 · Cited by 220
Mitochondrial Dysfunction and β-Cell Failure in Type 2 Diabetes Mellitus
Ma, Z. A., Zhao, Z., & Turk, J. (2012) · Experimental Diabetes Research · doi:10.1155/2012/703538 · Cited by 215
Phenotypic sexual dimorphism in response to dietary fat manipulation in C57BL/6J mice
Casimiro, I., Stull, N. D., Tersey, S. A., & Mirmira, R. G. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107795 · Cited by 212
Regulation of energy metabolism by the skeleton: osteocalcin and beyond
Ferron, M., & Lacombe, J. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.05.022 · Cited by 211
Lipotoxicity disrupts incretin-regulated human β cell connectivity
Hodson, D. J., Mitchell, R. K., Bellomo, E. A., Sun, G., Vinet, L., Meda, P., Li, D., Li, W.-H., Bugliani, M., Marchetti, P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68459 · Cited by 210
Beta cell apoptosis in diabetes
Thomas, H. E., McKenzie, M. D., Angstetra, E., Campbell, P. D., & Kay, T. W. (2009) · Apoptosis · doi:10.1007/s10495-009-0339-5 · Cited by 205
Diabetes and beta cell function: from mechanisms to evaluation and clinical implications
Cernea, S., & Dobreanu, M. (2013) · Biochemia Medica · doi:10.11613/bm.2013.033 · Cited by 203
“production of interleukin (IL)-1β, nuclear factor-kB (NF-kB) and Fas receptor) in islets, although this was not confirmed in other studies (13,18,31).”
BackgroundResultCerebral ischemic damage in diabetes: an inflammatory perspective
Shukla, V., Shakya, A. K., Perez-Pinzon, M. A., & Dave, K. R. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0774-5 · Cited by 200
“Type 1 diabetes (T1D) is characterized by loss of pancreatic β cells whereas type 2 diabetes (T2D) is the consequence of decreased insulin response (resistance) which in later stages is accompanied by failure of pancreatic β cells [3, 4].”
BackgroundSources and implications of NADH/NAD+ redox imbalance in diabetes and its complications
Yan, L.-J., Wu, J., Jin, Z., & Zheng, H. (2016) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s106087 · Cited by 198
Sauter, N. S., Schulthess, F. T., Galasso, R., Castellani, L. W., & Maedler, K. (2008) · Endocrinology · doi:10.1210/en.2007-1059 · Cited by 198
Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
Pechlivani, N., & Ajjan, R. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00001 · Cited by 197
“Rev Endocr Metab Disord (2010) 11(1):61–74.”
Glucagon Couples Hepatic Amino Acid Catabolism to mTOR-Dependent Regulation of α-Cell Mass
Solloway, M. J., Madjidi, A., Gu, C., Eastham-Anderson, J., Clarke, H. J., Kljavin, N., Zavala-Solorio, J., Kates, L., Friedman, B., Brauer, M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.034 · Cited by 194
Bindom, S. M., Hans, C. P., Xia, H., Boulares, A. H., & Lazartigues, E. (2010) · Diabetes · doi:10.2337/db09-0782 · Cited by 196
The Identification of Potential Factors Associated with the Development of Type 2 Diabetes
Lu, H., Yang, Y., Allister, E. M., Wijesekara, N., & Wheeler, M. B. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700478-mcp200 · Cited by 193
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Ardestani, A., Lupse, B., Kido, Y., Leibowitz, G., & Maedler, K. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.004 · Cited by 190
“…exposure of b cells to nutrient overload (glucose and free fatty acids, or FFAs) triggered by a carbohydrate- and fatrich diet is a major cause of b cell dysfunction in T2D (Alejandro et al., 2015; Leibowitz et al., 2010; Muoio and Newgard, 2008; Prentki and Nolan, 2006; Robertson et al., 2004).”
BackgroundZinc as a micronutrient and its preventive role of oxidative damage in cells
Kloubert, V., & Rink, L. (2015) · Food & Function · doi:10.1039/c5fo00630a · Cited by 191
Metadata
- Authors
- Prentki, M.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Prentki, M.
- ORCID
- Prentki, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1802-1812
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1483155
- OpenAlex
- W1598254642
- Cited by
- 1,690
- References
- 132
- Citations by year
- 2026: 52 · 2025: 52 · 2024: 46 · 2023: 54 · 2022: 68 · 2021: 95 · 2020: 95 · 2019: 111 · 2018: 90 · 2017: 109 · 2016: 112 · 2015: 107 · 2014: 131 · 2013: 97 · 2012: 98
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- ACT Government
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063356, DK63356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell failure, type 2 diabetes, obesity, beta-cell compensation, beta-cell mass expansion, insulin resistance, genetic susceptibility, intrauterine factors, environmental risk factors, beta-cell dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Disease Progression, Genetic Predisposition to Disease, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.